22-29674882-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000268.4(NF2):​c.1387G>A​(p.Glu463Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000909 in 1,573,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E463E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000057 ( 0 hom. )

Consequence

NF2
NM_000268.4 missense

Scores

1
10
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 8.12

Publications

20 publications found
Variant links:
Genes affected
NF2 (HGNC:7773): (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor) This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that link cytoskeletal components with proteins in the cell membrane. The encoded protein is involved in regulation of contact-dependent inhibition of cell proliferation and functions in cell-cell adhesion and transmembrane signaling. The encoded protein has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics, and proteins involved in regulating ion transport. Disruption of this protein's function has been implicated in tumorigenesis and metastasis. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. [provided by RefSeq, May 2022]
NF2 Gene-Disease associations (from GenCC):
  • NF2-related schwannomatosis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • familial meningioma
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037094235).
BP6
Variant 22-29674882-G-A is Benign according to our data. Variant chr22-29674882-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 237619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000407 (62/152304) while in subpopulation AFR AF = 0.00142 (59/41568). AF 95% confidence interval is 0.00113. There are 0 homozygotes in GnomAd4. There are 28 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 62 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000268.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF2
NM_000268.4
MANE Select
c.1387G>Ap.Glu463Lys
missense
Exon 13 of 16NP_000259.1
NF2
NM_001407066.1
c.1387G>Ap.Glu463Lys
missense
Exon 13 of 17NP_001393995.1
NF2
NM_016418.5
c.1387G>Ap.Glu463Lys
missense
Exon 13 of 17NP_057502.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF2
ENST00000338641.10
TSL:1 MANE Select
c.1387G>Ap.Glu463Lys
missense
Exon 13 of 16ENSP00000344666.5
NF2
ENST00000397789.3
TSL:1
c.1387G>Ap.Glu463Lys
missense
Exon 13 of 17ENSP00000380891.3
NF2
ENST00000403999.7
TSL:1
c.1387G>Ap.Glu463Lys
missense
Exon 13 of 16ENSP00000384797.3

Frequencies

GnomAD3 genomes
AF:
0.000407
AC:
62
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000964
AC:
18
AN:
186752
AF XY:
0.0000603
show subpopulations
Gnomad AFR exome
AF:
0.00134
Gnomad AMR exome
AF:
0.0000353
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000128
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000570
AC:
81
AN:
1420904
Hom.:
0
Cov.:
31
AF XY:
0.0000640
AC XY:
45
AN XY:
702766
show subpopulations
African (AFR)
AF:
0.00123
AC:
40
AN:
32578
American (AMR)
AF:
0.0000766
AC:
3
AN:
39142
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37710
South Asian (SAS)
AF:
0.0000248
AC:
2
AN:
80616
European-Finnish (FIN)
AF:
0.0000198
AC:
1
AN:
50498
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5728
European-Non Finnish (NFE)
AF:
0.0000229
AC:
25
AN:
1090410
Other (OTH)
AF:
0.000153
AC:
9
AN:
58848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000407
AC:
62
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.000376
AC XY:
28
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00142
AC:
59
AN:
41568
American (AMR)
AF:
0.00
AC:
0
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000177
Hom.:
0
Bravo
AF:
0.000461
ESP6500AA
AF:
0.00205
AC:
9
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000134
AC:
16

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Neurofibromatosis, type 2 (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.037
T
MetaSVM
Uncertain
0.29
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
8.1
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-1.3
N
REVEL
Uncertain
0.43
Sift
Benign
0.14
T
Sift4G
Benign
0.24
T
Polyphen
0.66
P
Vest4
0.46
MVP
0.85
MPC
1.4
ClinPred
0.061
T
GERP RS
5.6
Varity_R
0.11
gMVP
0.48
Mutation Taster
=39/61
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74315503; hg19: chr22-30070871; COSMIC: COSV58519919; API